Next 10 |
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 781,251 shares of its com...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its public offering of an aggregate of 781,251 shares of its common stock (or common sto...
Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, reports progress with advancing its product candidate NB1 into human clinical testing for spinal fusion. Following Human Research Ethics Committee (HREC) approval last year in Australia fo...
A look at the top 10 most actives in the United States SoundHound AI Inc. (SOUN) rose 46.7% to $5.75 on volume of 212,903,866 shares Akili Inc. (AKLI) rose 104.1% to $0.4523 on volume of 128,377,553 shares Charge Enterprises Inc. (CRGE) rose 8.7% to $0.0586 on volume of 119,330,728 shares...
2024-01-30 17:20:54 ET More on Bone Biologics Seeking Alpha’s Quant Rating on Bone Biologics Historical earnings data for Bone Biologics Financial information for Bone Biologics Read the full article on Seeking Alpha For further details see: ...
2024-01-22 12:31:12 ET Gainers: Sagimet Biosciences ( SGMT ) +106% . Rail Vision Ltd ( RVSN ) +51% . Digital World Acquisition Corp ( DWAC ) +49% . Bullfrog AI Holdings ( BFRG ) +38% . CXApp ( CXAI ) +34% . Phunware ( PHUN ...
Brings 20+ years of experience in finance and business operations at both public and private life sciences companies Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fus...
2024-01-10 08:22:21 ET More on Bone Biologics Seeking Alpha’s Quant Rating on Bone Biologics Historical earnings data for Bone Biologics Financial information for Bone Biologics For further details see: Bone Biologics regains compliance with Nasdaq...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets, today announced that it has received notice from The NASDAQ Stock Market LLC (Nasdaq) informing the Company that it ...
2024-01-05 17:22:19 ET More on Bone Biologics Seeking Alpha’s Quant Rating on Bone Biologics Historical earnings data for Bone Biologics Financial information for Bone Biologics For further details see: Bone Biologics files to sell 142.4K shares fo...
News, Short Squeeze, Breakout and More Instantly...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 781,251 shares of its com...
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioV...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its public offering of an aggregate of 781,251 shares of its common stock (or common sto...